Contrave® (naltrexone hydrochloride / bupropion hydrochloride)
Patient Adherence Program
PROGRAM OVERVIEW
This sponsored program aims to provide education and support to patients prescribed Contrave for weight management.
The program consists of a series of 4 messages delivered over approximately 3–4 months. It provides education and support during the initial stages of Contrave treatment to encourage patients to remain adherent through to their 16-week treatment review.
WHEN?
Commencing 31 July 2024.
FOR WHICH PATIENTS?
Messages will be delivered via the app/email or SMS to patients who are signed-up to MedAdvisor and are dispensed their first pack of Contrave, or who have had a break of 4+ months and are restarting treatment with Contrave.
Visit the Digital Adherence Program tile in PlusOne's Health Services Hub to learn more.